Genetically reprogrammed AIDs virus rescues girl from cancer

| December 10, 2012
Leukemia Treatment
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

In the first of its kind experimental treatment, Children’s Hospital of Philadelphia used a disabled form of the virus that causes AIDS to genetically reprogram a young girl’s immune system to kill cancer cells.The treatment nearly killed her, but she emerged from it cancer-free and seven months later is in remission.

View the original article here: In Girl’s Last Hope, Altered Immune Cells Beat Leukemia

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend